MAÜ GCRIS Standart veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

Protective effects of apocynin and melatonin on ovarian ischemia/reperfusion injury in rats

dc.contributor.author Unsal, Velid
dc.contributor.author İşgüder, Çiğdem Kunt
dc.contributor.author Can, Özlem Koşar
dc.contributor.author Pektaş, Mine Kanat
dc.contributor.author Arici, Akgül
dc.contributor.other Department of Nutrition and Dietetics/ Beslenme ve Diyetetik Bölümü
dc.date.accessioned 2021-07-24T09:38:38Z
dc.date.available 2021-07-24T09:38:38Z
dc.date.issued 2021
dc.department MAÜ, Fakülteler, Sağlık Bilimleri Fakültesi, Beslenme ve Diyetetik Bölümü en_US
dc.description.abstract Objective: This study aims to determine the protective effects of apocynin, a NADPH oxidase inhibitor, and melatonin, an endogenous anti-oxidant, in an animal model of ovarian ischemia/reperfusion (I/R) injury. Materials/Methods: Thirty-five female rats were randomly divided into five groups, namely group I (sham), group II (I/R), group III (I/R + 10 mg/kg apocynin), group IV (I/R + 20 mg/kg apocynin), and group V (I/R + 10 mg/kg melatonin). Ovarian tissue and serum superoxide dismutase (SOD) and catalase (CAT) activities and malondialdehyde (MDA) and protein carbonyl (PC) levels were measured. Ovarian histopathology was examined and Bax, caspase 3, and iNOS immunoreactivities were evaluated. Results: Preoperative apocynin and melatonin significantly increased SOD and CAT activities (P < 0.05, P < 0.05, P < 0.01, P < 0.01, P < 0.01, P < 0.05, P < 0.05, and P<0.01, respectively, for both apocynin and melatonin). In addition, preoperative apocynin and melatonin significantly decreased the ovarian I/R injury score (P < 0.01 for both). Bax, caspase 3, and iNOS immunoreactivities were significantly lower in the I/R + 10 mg/kg apocynin and I/R + 10 mg/kg melatonin groups than in the I/R group (P<0.01, P<0.01, P<0.01, P<0.01, P<0.05, and P<0.01, respectively). Conclusions: Apocynin and melatonin are powerful antioxidant agents with considerable bioavailability and safety. Preoperative apocynin and melatonin administration might protect ovarian tissue from I/R injury after surgical adnexal detorsion. en_US
dc.identifier.endpage 104 en_US
dc.identifier.issue 1 en_US
dc.identifier.scopus 2-s2.0-85099804246
dc.identifier.startpage 98 en_US
dc.identifier.uri https://www.scopus.com/record/display.uri?eid=2-s2.0-85099804246&doi=10.31083%2fj.ceog.2021.01.5488&origin=inward&txGid=af2c0713cb962c66df35bdcc96914ae5
dc.identifier.uri https://hdl.handle.net/20.500.12514/2691
dc.identifier.volume 48 en_US
dc.identifier.wos WOS:000613939700016
dc.identifier.wosquality Q4
dc.indekslendigikaynak Web of Science en_US
dc.indekslendigikaynak Scopus en_US
dc.language.iso en en_US
dc.publisher Clinical and Experimental Obstetrics and Gynecology en_US
dc.relation.ispartof Clinical and Experimental Obstetrics and Gynecology en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.scopus.citedbyCount 2
dc.subject Apocynin, Ischemia, Melatonin, Ovary, Reperfusion injury en_US
dc.title Protective effects of apocynin and melatonin on ovarian ischemia/reperfusion injury in rats en_US
dc.type Article en_US
dc.wos.citedbyCount 5
dspace.entity.type Publication
relation.isAuthorOfPublication 7c3a66b7-a957-40d9-a628-a536a623b015
relation.isAuthorOfPublication.latestForDiscovery 7c3a66b7-a957-40d9-a628-a536a623b015
relation.isOrgUnitOfPublication cbf35a4a-7e92-4e43-b898-3a77ba9a5cfd
relation.isOrgUnitOfPublication.latestForDiscovery cbf35a4a-7e92-4e43-b898-3a77ba9a5cfd

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Protectiveeffectsofapocyninandmelatoninonovarianischemia_reperfusioninjuryinrats.pdf
Size:
9.78 MB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.44 KB
Format:
Item-specific license agreed upon to submission
Description: